A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant Depression
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this multicenter study is to evaluate the efficacy of escitalopram
in treatment resistant depression (TRD), assessed by 2 consecutive failed antidepressant
treatments from different classes. The last treatment received is a 6 week prospective trial
with venlafaxine.